Contraception is the deliberate use of artificial methods to prevent pregnancy by interfering with the normal process of fertilization, ovulation, and implantation. The most common form of contraception, popularly known as fertility control or birth control, is a barrier method. It is available in two major forms in the market, namely, contraceptive drugs and devices. Contraceptive drugs include oral (pills), topical, and injectable contraceptives. Whereas, contraceptive devices include condom, Intrauterine devices (IUD), vaginal ring, implant, patch, diaphragms, sponges, and others. The major form of artificial contraception is the barrier method, especially condoms.
The world contraceptives market is expected to garner $43,812 million by 2022 from $28,175 million in 2015, registering a CAGR of 6.4% from 2016 to 2022. Increase in focus to prevent unwanted pregnancies, the incidence of STIs, and technological advancements in contraceptive methods majorly drive the market. Other birth control factors, such as family planning to improve the quality of life for both women and children and growth in adoption of modern contraceptives to control population have contributed majorly to the market growth. However, health risks associated with contraceptives, lack of social acceptance, and rise in prevalence of infertility among women hamper the Contraceptive market growth.
The world contraceptives market is segmented based on product, age group, education, end user, and geography. Based on product, the market is further segmented into contraceptive drugs and devices. Contraceptive drugs are further categorized into oral pills, topical, and injectable contraceptives. Among these, oral pills dominate the overall contraceptive drugs market, owing to their high success rate and increase in use as emergency contraceptive pills, also known as “morning pill”. In addition, contraceptive devices are further categorized into condom, IUD, vaginal ring, implant, patch, sponges, diaphragms, and others. Male condoms dominate the overall contraceptive device market due to the associated advantages such as cost-effective, fewer side effects, and ease of use.
Contraceptive market is further categorized by various age groups-15-24, 25-34, 35-44 and above 44 years, depending upon the usage and revenue generated by these age groups. On the basis of education the contraceptive market is further categorized into less than high school, high school graduate, college graduate, and other college degrees. Based on end user, the contraceptive market is segmented into household, hospitals, and, clinics. The world contraceptive market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA. These regions are further categorized into their respective countries. In 2015, North America accounted for the largest share in the contraceptive market due to factors, such as product innovations, large number of public awareness programs, and growth in incidence of unwanted pregnancies among teenagers. U.S. majorly contributes for the remarkable growth in North America especially due to the large consumer base for advanced contraception. In addition, the Asia-Pacific region is expected to offer lucrative opportunities to market players, due to increase in focus of key players to expand in the emerging economies, improvement of healthcare infrastructure, and growth in population in populace countries such as China and India.
Market players have adopted product launch and acquisition as their key strategies to sustain the intense competition in the contraceptives market. For instance, in May 2016, Allergan launched levonorgestrel-releasing intrauterine system (LILETTA) 52 mg, a hormone-releasing system placed in woman's uterus to prevent pregnancy for up to 3 years with effectiveness of more than 99%. Moreover, Actavis plc acquired Allergan, Inc. (U.S.), a pharmaceutical company to expand its product portfolio of women’s health and provide a robust platform for future product development.
KEY MARKET BENEFITS
KEY MARKET SEGMENTS:
The world contraceptives market is segmented into product, age group, education, end user, and geography.
BY END USER
By End User
Other players in the value chain include (profiles not included in the report)
The Global Surgical Scalpel market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Surgical Scalpel market, especially in North America, Europe, Asia-Pacific, South America, Middle ...
October 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Surgical Scalpel market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Surgical Scalpel in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and Philippines, focuses ...
October 2017 | $4660 |View Details>>
In 2016, the Surgical Scalpel market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include Hill-Rom Swann-Morton KAI Group ...
October 2017 | $3360 |View Details>>
In 2016, the Europe Surgical Scalpel market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Surgical Scalpel in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in ...
October 2017 | $4660 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research